| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| capmatinib | proto-oncogene c-met | NA | Successful target | TTD , DGIDB | Neoplasms[MeSHID:D009369] Mutation[MeSHID:D009154] epithelial to mesenchymal transition[MeSHID:D058750] Non-Small Cell Lung Carcinoma[MeSHID:D002289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver carcinoma[MeSHID:D006528] Recurrence (disease attribute)[MeSHID:D012008] Glioblastoma[MeSHID:D005909] |
2.48 | approved | inhibitor |
| capmatinib | hepatocyte growth factor receptor | small molecule | NA | drugbank , DGIDB | Neoplasms[MeSHID:D009369] Mutation[MeSHID:D009154] epithelial to mesenchymal transition[MeSHID:D058750] Non-Small Cell Lung Carcinoma[MeSHID:D002289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver carcinoma[MeSHID:D006528] Recurrence (disease attribute)[MeSHID:D012008] Glioblastoma[MeSHID:D005909] |
2.48 | approved,investigational | inhibitor |
| capmatinib | proto-oncogene c-met | NA | Successful target | TTD , DGIDB | Neoplasms[MeSHID:D009369] Mutation[MeSHID:D009154] epithelial to mesenchymal transition[MeSHID:D058750] Non-Small Cell Lung Carcinoma[MeSHID:D002289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver carcinoma[MeSHID:D006528] Recurrence (disease attribute)[MeSHID:D012008] Glioblastoma[MeSHID:D005909] |
2.48 | approved | unknown |
| click here to return to the previous page | ||||||||